SI
SUPERNUS INC
SUPN· Health Care· PharmaceuticalsS&P 600
Close · 12/11/2026
29.20
1D
-0.85%52-week range
25.92 – 59.68
Volume
43,65,800.00
Price history
SUPN
14/10/2026 to 12/11/2026
O 29.48 H 30.18 L 28.79
1W+9.20%
1M-27.33%
3M-39.51%
6M-42.97%
1Y-36.67%
3Y+22.38%
5Y-7.48%
MAX+9.82%
Fundamentals
as of 12/11/2026- Market cap
- $3.45B
- Shares out
- 118.04M
- P/E (trailing)
- 7.64
- P/E (forward)
- 7.42
- EPS (trailing)
- 3.82
- Dividend yield
- 0.00%
- Beta
- 1.13
- Profit margin
- 32.85%
- P/B
- -58.50
SEC financial statements
10 quarterly and 4 annual periods through 30/09/2026.
Details
- Ticker
- SUPN
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
2 filers · 1 on watchlist · 3 buys · 2 sells · D: 5
- 03/03/2026Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/12/2025Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 09/10/2025Gilbert CisnerosSell+Supernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 24/03/2025Gilbert CisnerosBuySupernus Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 23/12/2022Josh GottheimerWSell+Supernus Pharmaceuticals, Inc.$1,001–$15,000